Seelos Therapeutics, Inc. Convertible Debt
Seelos Therapeutics, Inc. had Convertible Debt of $13.69 million as of 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2021-11-05
- 2021-09-30: Convertible Debt $13.69M.
- 2021-06-30: Convertible Debt $13.69M.
- 2021-03-31: Convertible Debt $13.69M.
- 2020-12-31: Convertible Debt $13.69M.
| Period end | Convertible Debt |
|---|---|
| 2021-09-30 | $13.69M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $13.69M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $13.69M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $13.69M 10-Q · filed 2021-11-05 |